{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T07:11:23Z","timestamp":1774077083527,"version":"3.50.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004462","name":"Consiglio Nazionale delle Ricerche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004462","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.phrs.2012.12.002","type":"journal-article","created":{"date-parts":[[2012,12,17]],"date-time":"2012-12-17T00:33:38Z","timestamp":1355704418000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Pharmacodynamic potentiation of antiepileptic drugs\u2019 effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA\/2 mice"],"prefix":"10.1016","volume":"70","author":[{"given":"Emilio","family":"Russo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Donato di Paola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Gareri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Siniscalchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Labate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Gallelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Citraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovambattista","family":"De Sarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2012.12.002_bib0005","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1528-1167.2010.02520.x","article-title":"Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy","volume":"51","author":"Canevini","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2012.12.002_bib0010","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1111\/j.1528-1167.2011.03325.x","article-title":"Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments","volume":"52","author":"Luoni","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2012.12.002_bib0015","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/sj.jcbfm.9600116","article-title":"Statins and stroke","volume":"25","author":"Endres","year":"2005","journal-title":"Journal of Cerebral Blood Flow & Metabolism"},{"key":"10.1016\/j.phrs.2012.12.002_bib0020","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/89058","article-title":"Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site","volume":"7","author":"Weitz-Schmidt","year":"2001","journal-title":"Nature Medicine"},{"key":"10.1016\/j.phrs.2012.12.002_bib0025","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1212\/01.wnl.0000317006.87071.b1","article-title":"Re: Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease","volume":"70","author":"Golomb","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2012.12.002_bib0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1741-7015-5-20","article-title":"Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease","volume":"5","author":"Wolozin","year":"2007","journal-title":"BMC Medicine"},{"key":"10.1016\/j.phrs.2012.12.002_bib0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/089771504772695913","article-title":"Atorvastatin reduces neurological deficit and increases synaptogenesis, angiogenesis, and neuronal survival in rats subjected to traumatic brain injury","volume":"21","author":"Lu","year":"2004","journal-title":"Journal of Neurotrauma"},{"key":"10.1016\/j.phrs.2012.12.002_bib0040","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1212\/WNL.0b013e3181f96253","article-title":"Statin use and risk of epilepsy: a nested case\u2013control study","volume":"75","author":"Etminan","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2012.12.002_bib0045","doi-asserted-by":"crossref","first-page":"11104","DOI":"10.1523\/JNEUROSCI.23-35-11104.2003","article-title":"3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity","volume":"23","author":"Zacco","year":"2003","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.phrs.2012.12.002_bib0050","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1161\/01.STR.31.10.2442","article-title":"Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice","volume":"31","author":"Laufs","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.phrs.2012.12.002_bib0055","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1179\/174313208X353686","article-title":"Impact of statins on validation of ICH mortality prediction models","volume":"31","author":"Naval","year":"2009","journal-title":"Neurological Research"},{"key":"10.1016\/j.phrs.2012.12.002_bib0060","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1111\/j.1528-1167.2011.03261.x","article-title":"Differential effects of atorvastatin treatment and withdrawal on pentylenetetrazol-induced seizures","volume":"52","author":"Funck","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2012.12.002_bib0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/JAD-2010-101653","article-title":"Simvastatin is the statin that most efficiently protects against kainate-induced excitotoxicity and memory impairment","volume":"24","author":"Ramirez","year":"2011","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.phrs.2012.12.002_bib0070","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1528-1167.2011.03073.x","article-title":"Atorvastatin treatment during epileptogenesis in a rat model for temporal lobe epilepsy","volume":"52","author":"van Vliet","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2012.12.002_bib0075","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12640-009-9057-6","article-title":"Atorvastatin prevents hippocampal cell death due to quinolinic acid-induced seizures in mice by increasing Akt phosphorylation and glutamate uptake","volume":"16","author":"Piermartiri","year":"2009","journal-title":"Neurotoxicity Research"},{"key":"10.1016\/j.phrs.2012.12.002_bib0080","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neulet.2008.05.112","article-title":"Statin inhibits kainic acid-induced seizure and associated inflammation and hippocampal cell death","volume":"440","author":"Lee","year":"2008","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.phrs.2012.12.002_bib0085","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.expneurol.2010.08.030","article-title":"Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-beta (1\u201340) administration in mice: evidence for dissociation between cognitive deficits and neuronal damage","volume":"226","author":"Piermartiri","year":"2010","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.phrs.2012.12.002_bib0090","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1590\/S0004-282X2005000600013","article-title":"Lovastatin reduces neuronal cell death in hippocampal CA1 subfield after pilocarpine-induced status epilepticus: preliminary results","volume":"63","author":"Rangel","year":"2005","journal-title":"Arquivos de neuro-psiquiatria"},{"key":"10.1016\/j.phrs.2012.12.002_bib0095","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00005344-199302000-00022","article-title":"Comparison of fluvastatin and lovastatin blood\u2013brain barrier transfer using in vitro and in vivo methods","volume":"21","author":"Guillot","year":"1993","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.phrs.2012.12.002_bib0100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0165-6147(97)01147-4","article-title":"Hydrophilicity\/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors","volume":"19","author":"Hamelin","year":"1998","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.phrs.2012.12.002_bib0105","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1124\/jpet.104.075028","article-title":"Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex","volume":"312","author":"Johnson-Anuna","year":"2005","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.phrs.2012.12.002_bib0110","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.eplepsyres.2007.04.008","article-title":"Influence of levetiracetam on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA\/2 mice","volume":"75","author":"Donato Di Paola","year":"2007","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.phrs.2012.12.002_bib0115","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1016\/j.bmc.2007.05.059","article-title":"Synthesis, resolution, stereochemistry, and molecular modeling of (R)- and (S)-2-acetyl-1-(4\u2032-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline AMPAR antagonists","volume":"15","author":"Gitto","year":"2007","journal-title":"Bioorganic and Medicinal Chemistry"},{"key":"10.1016\/j.phrs.2012.12.002_bib0120","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eplepsyres.2011.02.013","article-title":"Preclinical activity profile of alpha-lactalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy","volume":"95","author":"Citraro","year":"2011","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.phrs.2012.12.002_bib0125","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0014-2999(98)00193-9","article-title":"Gabapentin potentiates the antiseizure activity of certain anticonvulsants in DBA\/2 mice","volume":"349","author":"De Sarro","year":"1998","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.phrs.2012.12.002_bib0130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0014-2999(00)00086-8","article-title":"7-Nitroindazole potentiates the antiseizure activity of some anticonvulsants in DBA\/2 mice","volume":"394","author":"De Sarro","year":"2000","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.phrs.2012.12.002_bib0135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.phrs.2011.11.005","article-title":"Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA\/2 mice","volume":"65","author":"Sarro","year":"2012","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.phrs.2012.12.002_bib0140","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0014-2999(02)01536-4","article-title":"Influence of some beta-adrenoceptor antagonists on the anticonvulsant potency of antiepileptic drugs against audiogenic seizures in DBA\/2 mice","volume":"442","author":"De Sarro","year":"2002","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.phrs.2012.12.002_bib0145","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1111\/j.1528-1167.2009.02400.x","article-title":"Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy","volume":"51","author":"Russo","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2012.12.002_bib0150","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jps.3030460322","article-title":"A note on a simple apparatus for detecting neurological deficit in rats and mice","volume":"46","author":"Dunham","year":"1957","journal-title":"Journal of the American Pharmaceutical Association"},{"key":"10.1016\/j.phrs.2012.12.002_bib0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1742-7843.2004.pto940205.x","article-title":"Anticonvulsant profile of flunarizine and relation to Na(+) channel blocking effects","volume":"94","author":"Fischer","year":"2004","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"10.1016\/j.phrs.2012.12.002_bib0160","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1159\/000341433","article-title":"Atorvastatin and simvastatin, but not pravastatin, up-regulate LPS-induced MMP-9 expression in macrophages by regulating phosphorylation of ERK and CREB","volume":"30","author":"Lee","year":"2012","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/j.phrs.2012.12.002_bib0165","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.yebeh.2010.07.024","article-title":"The effects of atorvastatin on memory deficit and seizure susceptibility in pentylentetrazole-kindled rats","volume":"19","author":"Uzum","year":"2010","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.phrs.2012.12.002_bib0170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejphar.2011.10.030","article-title":"The interactions of atorvastatin and fluvastatin with carbamazepine, phenytoin and valproate in the mouse maximal electroshock seizure model","volume":"674","author":"Stepien","year":"2012","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.phrs.2012.12.002_bib0175","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000112177","article-title":"Clinical aspects of Niemann-Pick type C disease in the adult","volume":"13","author":"Turpin","year":"1991","journal-title":"Developmental Neuroscience"},{"key":"10.1016\/j.phrs.2012.12.002_bib0180","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1194\/jlr.M400097-JLR200","article-title":"Lovastatin exacerbates atypical absence seizures with only minimal effects on brain sterols","volume":"45","author":"Serbanescu","year":"2004","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.phrs.2012.12.002_bib0185","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-2010-101179","article-title":"Statins as neuroprotectants: a comparative in vitro study of lipophilicity, blood\u2013brain-barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death","volume":"23","author":"Sierra","year":"2011","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.phrs.2012.12.002_bib0190","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1471-4159.2004.02980.x","article-title":"Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones","volume":"92","author":"Bosel","year":"2005","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.phrs.2012.12.002_bib0195","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.expneurol.2008.11.016","article-title":"High dose of simvastatin induces hyperlocomotive and anxiolytic-like activities: the association with the up-regulation of NMDA receptor binding in the rat brain","volume":"216","author":"Wang","year":"2009","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.phrs.2012.12.002_bib0200","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/STROKEAHA.107.498923","article-title":"Simvastatin reduces the association of NMDA receptors to lipid rafts: a cholesterol-mediated effect in neuroprotection","volume":"39","author":"Ponce","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.phrs.2012.12.002_bib0205","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.neuroscience.2008.04.026","article-title":"Chronic treatment with simvastatin upregulates muscarinic M1\/4 receptor binding in the rat brain","volume":"154","author":"Wang","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2012.12.002_bib0210","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1592\/phco.26.11.1601","article-title":"Role of P-glycoprotein in statin drug interactions","volume":"26","author":"Holtzman","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.phrs.2012.12.002_bib0215","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.eplepsyres.2010.07.021","article-title":"The association between antiepileptic drug and HMG-CoA reductase inhibitor co-medication and cholesterol management in patients with epilepsy","volume":"91","author":"Candrilli","year":"2010","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.phrs.2012.12.002_bib0220","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.phrs.2011.09.003","article-title":"Antiepileptic drugs for central post-stroke pain management","volume":"65","author":"Siniscalchi","year":"2012","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.phrs.2012.12.002_bib0225","first-page":"611","article-title":"Are pleiotropic effects of statins real","volume":"3","author":"Corsini","year":"2007","journal-title":"Journal of Vascular Health and Risk Management"},{"key":"10.1016\/j.phrs.2012.12.002_bib0230","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.yebeh.2012.02.001","article-title":"Chronic administration of atorvastatin induced anti-convulsant effects in mice: the role of nitric oxide","volume":"23","author":"Moezi","year":"2012","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.phrs.2012.12.002_bib0235","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1472-8206.1991.tb00737.x","article-title":"Role of nitric oxide in the genesis of excitatory amino acid-induced seizures from the deep prepiriform cortex","volume":"5","author":"De Sarro","year":"1991","journal-title":"Fundamental and Clinical Pharmacology"},{"key":"10.1016\/j.phrs.2012.12.002_bib0240","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0014-2999(93)90797-L","article-title":"l-Arginine potentiates excitatory amino acid-induced seizures elicited in the deep prepiriform cortex","volume":"230","author":"De Sarro","year":"1993","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.phrs.2012.12.002_bib0245","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.pbb.2006.11.016","article-title":"Amino acid levels in some brain areas of inducible nitric oxide synthase knock out mouse (iNOS\u2212\/\u2212) before and after pentylenetetrazole kindling","volume":"85","author":"De Luca","year":"2006","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.phrs.2012.12.002_bib0250","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.phrs.2007.02.001","article-title":"Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice","volume":"55","author":"Monetti","year":"2007","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.phrs.2012.12.002_bib0255","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jns.2008.07.029","article-title":"Atorvastatin enhances hypothermia-induced neuroprotection after stroke","volume":"275","author":"Lee","year":"2008","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.phrs.2012.12.002_bib0260","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1161\/STROKEAHA.107.485045","article-title":"Delayed postischemic treatment with fluvastatin improved cognitive impairment after stroke in rats","volume":"38","author":"Shimamura","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.phrs.2012.12.002_bib0265","first-page":"328","article-title":"Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction","volume":"11","author":"Comparato","year":"2001","journal-title":"Nutrition, Metabolism & Cardiovascular Diseases"},{"key":"10.1016\/j.phrs.2012.12.002_bib0270","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2184.2012.00846.x","article-title":"Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non-small lung cancer cells","volume":"45","author":"Pelaia","year":"2012","journal-title":"Cell Proliferation"},{"key":"10.1016\/j.phrs.2012.12.002_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2004.02.083","article-title":"Simvastatin prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion and protein tyrosine nitration in mice","volume":"1037","author":"Selley","year":"2005","journal-title":"Brain Research"},{"key":"10.1016\/j.phrs.2012.12.002_bib0280","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)02149-6","article-title":"Glutamate metabotropic receptors as targets for drug therapy in epilepsy","volume":"476","author":"Moldrich","year":"2003","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.phrs.2012.12.002_bib0285","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pbb.2005.02.012","article-title":"Amino acid levels in some lethargic mouse brain areas before and after pentylenetetrazole kindling","volume":"81","author":"De Luca","year":"2005","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.phrs.2012.12.002_bib0290","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.neuropharm.2012.06.039","article-title":"Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity","volume":"64","author":"Russo","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2012.12.002_bib0295","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.eplepsyres.2010.09.001","article-title":"Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X)","volume":"92","author":"Bialer","year":"2010","journal-title":"Epilepsy Research"},{"issue":"Suppl. 9","key":"10.1016\/j.phrs.2012.12.002_bib0300","first-page":"S7","article-title":"Identification and preclinical testing of novel antiepileptic compounds","volume":"38","author":"Meldrum","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2012.12.002_bib0305","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.neuropharm.2003.11.028","article-title":"Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy","volume":"46","author":"Russo","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2012.12.002_bib0310","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.bjp.0705617","article-title":"Topiramate hyperpolarizes and modulates the slow poststimulus AHP of rat olfactory cortical neurones in vitro","volume":"141","author":"Russo","year":"2004","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.phrs.2012.12.002_bib0315","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/157015910793358187","article-title":"Use of antiepileptic drugs for hyperkinetic movement disorders","volume":"8","author":"Siniscalchi","year":"2010","journal-title":"Current Neuropharmacology"},{"key":"10.1016\/j.phrs.2012.12.002_bib0320","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1345\/aph.1Q013","article-title":"Effects of carbamazepine\/oxycodone coadministration in the treatment of trigeminal neuralgia","volume":"45","author":"Siniscalchi","year":"2011","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1016\/j.phrs.2012.12.002_bib0325","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1734-1140(12)70727-2","article-title":"What's the role of topiramate in the management of patients with hyperkinetic movement disorders","volume":"64","author":"Siniscalchi","year":"2012","journal-title":"Pharmacological Reports"},{"key":"10.1016\/j.phrs.2012.12.002_bib0330","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1684\/epd.2012.0497","article-title":"Topiramate and temporal lobe epilepsy: an open-label study","volume":"14","author":"Labate","year":"2012","journal-title":"Epileptic Disorders"},{"key":"10.1016\/j.phrs.2012.12.002_bib0335","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/NDT.S1655","article-title":"Monotherapy for partial epilepsy: focus on levetiracetam","volume":"4","author":"Gambardella","year":"2008","journal-title":"Journal of Neuropsychiatric Disease and Treatment"},{"key":"10.1016\/j.phrs.2012.12.002_bib0340","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0074-7742(06)81015-9","article-title":"Risk and predictability of drug interactions in the elderly","volume":"81","author":"Levy","year":"2007","journal-title":"International Review of Neurobiology"},{"key":"10.1016\/j.phrs.2012.12.002_bib0345","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/01.wnl.0000341789.77291.8d","article-title":"Assessment of potential drug interactions in patients with epilepsy: impact of age and sex","volume":"72","author":"Gidal","year":"2009","journal-title":"Neurology"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661812002381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661812002381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T10:45:38Z","timestamp":1772880338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661812002381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S1043661812002381"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2012.12.002","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacodynamic potentiation of antiepileptic drugs\u2019 effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA\/2 mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2012.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}